Day: September 11, 2023

American Battery Solutions, Inc.’s ESS Division Completes Spin-Out, Establishes American Energy Storage Innovations, Inc.

The new independent company charts enormous success with industry leader Bud Collins at the helm. BOSTON and DETROIT, Sept. 11, 2023 (GLOBE NEWSWIRE) — Today, just ahead of the RE+ exhibition, American Battery Solutions, Inc. (ABS) is pleased to announce the spin-out of its Energy Storage Solutions Division (ABS-ESS) to create a new company: American […]

Continue Reading »

Duck Creek Technologies Announces New Chief Financial Officer

Company appoints Teresa M. Kim, experienced technology finance executive, to oversee finance and accounting functions Duck Creek Technologies Announces New Chief Financial Officer BOSTON, Sept. 11, 2023 (GLOBE NEWSWIRE) — Duck Creek Technologies, the intelligent solutions provider defining the future of property and casualty (P&C) and general insurance, announces the appointment of Teresa M. Kim as […]

Continue Reading »

WillScot Mobile Mini Announces $500 Million Senior Secured Notes Offering

PHOENIX, Sept. 11, 2023 (GLOBE NEWSWIRE) — WillScot Mobile Mini Holdings Corp. (“WillScot Mobile Mini” or the “Company”) (Nasdaq: WSC), the North American leader in innovative flexible space and storage solutions, today announced that its indirect subsidiary Williams Scotsman, Inc. (“WSI”) plans to offer, subject to market and other conditions, $500 million aggregate principal amount […]

Continue Reading »

New Data From an Influenza Challenge Study Further Support the Prophylactic Potential of INNA-051 to Accelerate Viral Clearance

– INNA-051 increased early expression of multiple antiviral effector genes compared with placebo and shortened viral shedding duration in participants with confirmed influenza infection MELBOURNE, Australia and MILAN, Italy, Sept. 11, 2023 (GLOBE NEWSWIRE) — ENA Respiratory, a clinical-stage pharmaceutical company, announced positive data from the Phase 2a flu challenge study of INNA-051, a first-in-class, […]

Continue Reading »

Samsung Bioepis Partners with Sandoz to Commercialize Ustekinumab Biosimilar Candidate

Enters into a commercialization agreement for SB17, ustekinumab biosimilar candidate, in Europe and North America Partnership to support Samsung Bioepis pipeline expansion and provide increased access to biosimilars INCHEON, Korea, Sept. 11, 2023 (GLOBE NEWSWIRE) — Samsung Bioepis Co., Ltd. today announced that it has entered into a commercialization agreement with Sandoz for SB17, a […]

Continue Reading »
Popular Posts
September 2023